What are the best healthcare stocks in 2026?

Based on AI conviction analysis, the top best healthcare stocks include HCA, AMGN, RIGL, IQV, ABBV. Each stock is scored on quality, fair value, and risk-reward asymmetry.

How are best healthcare stocks ranked?

Stocks are ranked by AI conviction score (1-10) using fundamental analysis: DCF valuation, earnings quality, Monte Carlo scenarios, and risk-reward asymmetry. Each stock also receives a quality grade (A-F) and a rating from Strong Buy to Avoid.

All categories

Best Healthcare Stocks

Top healthcare and pharma stocks ranked by conviction score, fair value, and quality. Defensive names with durable demand.

84 stocks

#	Ticker	Company	Rating	Convex Score	Fair Value	Upside	Quality
1	HCA	HCA Healthcare, Inc.	Score A	10/10	$715	+93.0%	B	View
2	AMGN	Amgen Inc.	Score A	10/10	$583	+60.2%	B	View
3	RIGL	Rigel Pharmaceuticals, Inc.	Score A+	10/10	$49	+24.5%	A	View
4	IQV	IQVIA Holdings Inc.	Score A	10/10	$309	+50.0%	C	View
5	ABBV	AbbVie Inc.	Score A	10/10	$249	-2.3%	C	View
6	JNJ	Johnson & Johnson	Score A+	10/10	$312	+23.2%	A	View
7	ABT	Abbott Laboratories	Score B	10/10	$90	-11.1%	B	View
8	DGX	Quest Diagnostics Incorporated	Score A	10/10	$283	+36.4%	B	View
9	BIO	Bio-Rad Laboratories, Inc.	Score A	10/10	$322	+6.7%	C	View
10	BIIB	Biogen Inc.	Score A	10/10	$260	+30.0%	C	View
11	VTRS	Viatris Inc.	Score B	10/10	$22	+30.0%	D	View
12	BMY	Bristol-Myers Squibb Company	Score A	10/10	$66	+9.4%	C	View
13	BSX	Boston Scientific Corporation	Score A	10/10	$83	+88.5%	C	View
14	CNC	Centene Corp.	Score D	10/10	$171	+159.3%	F	View
15	DHR	Danaher Corporation	Score B	10/10	$250	+24.4%	B	View
16	CI	Cigna Corporation	Score A	10/10	$534	+88.1%	C	View
17	DXCM	DexCom, Inc.	Score A+	10/10	$102	+34.8%	A	View
18	COR	Cencora, Inc.	Score A	10/10	$528	+73.6%	B	View
19	COO	The Cooper Companies, Inc.	Score B	10/10	$90	+24.8%	C	View
20	GILD	Gilead Sciences, Inc.	Score A+	10/10	$173	+30.0%	A	View
21	GEHC	GE HealthCare Technologies Inc.	Score B	10/10	$82	+30.0%	C	View
22	EW	Edwards Lifesciences Corporation	Score A	10/10	$70	-18.2%	A	View
23	HOLX	Hologic, Inc.	Score A	10/10	$93	+22.3%	C	View
24	IDXX	IDEXX Laboratories, Inc.	Score B	10/10	$491	-12.9%	A	View
25	MOH	Molina Healthcare, Inc.	Score A	10/10	$365	+59.1%	C	View
26	LLY	Eli Lilly and Company	Score A+	10/10	$1,405	+22.5%	A	View
27	MCK	McKesson Corporation	Score A	10/10	$1,552	+86.7%	C	View
28	LH	Labcorp Holdings Inc.	Score A	10/10	$376	+33.6%	C	View
29	MRK	Merck & Co., Inc.	Score A+	10/10	$158	+26.6%	A	View
30	PODD	Insulet Corp.	Score A+	10/10	$296	+77.0%	A	View
31	RVTY	Revvity, Inc.	Score A	10/10	$137	+24.8%	C	View
32	REGN	Regeneron Pharmaceuticals, Inc.	Score B	10/10	$1,008	+50.0%	B	View
33	STE	STERIS plc	Score B	10/10	$272	+26.7%	C	View
34	SYK	Stryker Corporation	Score A	10/10	$481	+50.3%	B	View
35	SOLV	Solventum Corporation	Score A	10/10	$90	+13.1%	B	View
36	UNH	UnitedHealth Group Incorporated	Score A	10/10	$714	+69.3%	C	View
37	ZTS	Zoetis Inc.	Score A	10/10	$115	+50.0%	A	View
38	VRTX	Vertex Pharmaceuticals Incorporated	Score A	10/10	$452	-7.0%	A	View
39	UHS	Universal Health Services, Inc.	Score A	10/10	$292	+93.6%	B	View
40	ZBH	Zimmer Biomet Holdings, Inc.	Score B	10/10	$113	+26.1%	C	View
41	AZN	AstraZeneca PLC	Score B	10/10	$247	+49.8%	B	View
42	GSK	GSK plc	Score B	10/10	$74	+47.5%	B	View
43	SNY	Sanofi	Score B	10/10	$61	+38.3%	C	View
44	NVO	Novo Nordisk A/S	Score B	10/10	$79	+58.3%	A	View
45	NVS	Novartis AG	Score A+	10/10	$285	+90.3%	A	View
46	DOCS	Doximity, Inc.	Score A+	10/10	$38	+75.6%	A	View
47	ALHC	Alignment Healthcare, Inc.	Score D	10/10	$26	+23.5%	F	View
48	ARGX	argenx SE	Score A	10/10	$1,206	+42.5%	C	View
49	ELV	Elevance Health Inc.	Score A	10/10	$625	+63.4%	C	View
50	ONC	BeOne Medicines AG	Score B	10/10	$293	-5.6%	C	View
51	ALNY	Alnylam Pharmaceuticals, Inc.	Score A	10/10	$360	+32.1%	A	View
52	ISRG	Intuitive Surgical, Inc.	Score B	10/10	$324	-8.2%	A	View
53	RMD	ResMed Inc.	Score A+	10/10	$354	+78.1%	A	View
54	INCY	Incyte Corporation	Score A+	10/10	$204	+76.0%	A	View
55	ALGN	Align Technology, Inc.	Score B	9/10	$205	+17.4%	B	View
56	HSIC	Henry Schein, Inc.	Score B	9/10	$129	+50.0%	D	View
57	CAH	Cardinal Health, Inc.	Score B	9/10	$372	+64.9%	D	View
58	BDX	Becton, Dickinson and Company	Score B	8/10	$201	+30.0%	D	View
59	ILMN	Illumina, Inc.	Score A	8/10	$167	-9.6%	C	View
60	HUM	Humana Inc.	Score B	8/10	$372	-6.5%	D	View
61	TMO	Thermo Fisher Scientific Inc.	Score B	8/10	$507	-3.7%	C	View
62	TECH	Bio-Techne Corporation	Score B	8/10	$39	-46.2%	B	View
63	TFX	Teleflex Incorporated	Score B	8/10	$147	+9.5%	D	View
64	WST	West Pharmaceutical Services, Inc.	Score B	8/10	$216	-38.7%	A	View
65	DVA	DaVita Inc.	Score B	7/10	$265	+13.3%	D	View
66	MTD	Mettler-Toledo International Inc.	Score B	7/10	$1,195	-6.2%	A	View
67	CVS	CVS Health Corp.	Score B	6/10	$125	+16.0%	D	View
68	HIMS	Hims & Hers Health, Inc.	Score A (Speculative)	6/10	$58	+77.3%	B	View
69	TEM	Tempus AI, Inc.	Score B (Speculative)	6/10	$85	+76.3%	B	View
70	PFE	Pfizer Inc.	Score B	5/10	$24	-1.2%	D	View
71	WAT	Waters Corporation	Score B	5/10	$298	-16.7%	B	View
72	OSCR	Oscar Health, Inc.	Score B (Speculative)	4/10	$31	+6.2%	C	View
73	WBA	Walgreens Boots Alliance, Inc.	Score D	4/10	$15	+27.4%	F	View
74	NTRA	Natera, Inc.	Score B (Speculative)	4/10	$300	+14.4%	A	View
75	CRL	Charles River Laboratories International, Inc.	Score D	3/10	$143	-34.8%	D	View
76	GH	Guardant Health, Inc.	Score B (Speculative)	3/10	$147	-0.4%	C	View
77	VKTX	Viking Therapeutics, Inc.	Score D (Speculative)	2/10	$33	-9.2%	F	View
78	EXAS	Exact Sciences Corporation	Score D	2/10	$41	-61.1%	D	View
79	CTLT	Catalent, Inc.	Score D (Speculative)	1/10	$33	-48.1%	F	View
80	BAX	Baxter International Inc.	Score D (Speculative)	1/10	$16	-27.6%	D	View
81	MRNA	Moderna, Inc.	Score D (Speculative)	1/10	$32	-46.8%	D	View
82	RVMD	Revolution Medicines, Inc.	Score D (Speculative)	1/10	$116	-35.5%	D	View
83	ROIV	Roivant Sciences Ltd.	Score D (Speculative)	1/10	$3	-92.1%	C	View
84	VRAX	Virax Biolabs Group Limited	Score D (Speculative)	1/10	$1	-74.3%	C	View

Methodology

Stocks are selected using our 8-step AI conviction framework, which evaluates quality, fair value (PEG, FCF DCF, EV/EBITDA), scenario modeling, and risk/reward asymmetry. The list is updated regularly as new analyses are processed.